Session Type
Meeting
Search Results for Cancer
Oral Presentations
Abstract Number: 0014
SHM Converge 2025
Background: Preventive care is a crucial but underutilized component of optimal population health management. Of eligible patients, 69.0% have received pneumococcal vaccine, 24.1% zoster vaccine, and 30.0% hepatitis B vaccine. Cancer screening rates are similarly low, with 12.5% screened for lung cancer and 71.6% for colorectal cancer. Gaps in preventive care are even larger in [...]
Oral Presentations
Abstract Number: 0014
SHM Converge 2025
Background: Preventive care is a crucial but underutilized component of optimal population health management. Of eligible patients, 69.0% have received pneumococcal vaccine, 24.1% zoster vaccine, and 30.0% hepatitis B vaccine. Cancer screening rates are similarly low, with 12.5% screened for lung cancer and 71.6% for colorectal cancer. Gaps in preventive care are even larger in [...]
Abstract Number: 0043
SHM Converge 2025
Case Presentation: A 40-year-old woman with a history of bipolar disorder and cannabis use disorder presented with four days of headache, dizziness, and vomiting. Initial examination revealed no focal neurological deficits except inconsistent orientation to time and cognitive slowing. She was treated symptomatically and planned for discharge. As she attempted to leave the ED, she [...]
Abstract Number: 0085
SHM Converge 2025
Background: Effective communication affects cancer management and outcomes and is particularly essential in the last year of life when medical complexity peaks. In the last decade, adoption of telemedicine and other advances may have affected patient experience and communication effectiveness. The purpose of this study is to assess racial disparities and trends in patient experience [...]
Abstract Number: 0105
SHM Converge 2025
Background: Substance use and mental health disorders significantly contribute to disparities in cancer care, particularly in the South Bronx, a region with a large Latinx and Black population. This study evaluates the impact of these disorders on cancer care among newly diagnosed patients at Lincoln Cancer Center. Methods: This retrospective study included newly diagnosed cancer [...]
Abstract Number: 0268
SHM Converge 2025
Background: Delirium, an acute neuropsychiatric syndrome marked by fluctuating disturbances in attention, cognition, and consciousness, is prevalent among older hospitalized cancer patients. The Mayo Delirium Prediction (MDP) tool, designed to predict delirium risk in older adults using electronic health record (EHR) data, may help identify individuals at increased risk, thus offering valuable insights for targeted [...]
Abstract Number: 0574
SHM Converge 2025
Case Presentation: A 57-year-old man with history of Stage IV pancreatic adenocarcinoma, coronary artery disease, and deep venous thrombosis presented to the emergency room with chest pain and acute bilateral lower extremity swelling. The chest pain began several hours prior to admission and the swelling developed over the past 3 days. On exam, he had [...]
Abstract Number: 0592
SHM Converge 2025
Case Presentation: A 71-year-old woman with a past medical history of hypertension presented for right sided flank pain and post-menopausal bleeding. The initial CT abdomen and pelvis demonstrated bilateral pleural effusions, diffuse lymphadenopathy, and right sided ureteropelvic junction (UPJ) stenosis with hydronephrosis. She underwent lymph node fine needle aspiration (FNA) and then transferred to our [...]
Abstract Number: 0595
SHM Converge 2025
Case Presentation: A 38-year-old woman with suspected metastatic right breast cancer presented to the acute care hospital for a second opinion. The patient first noticed a breast lump one year ago and had been receiving homeopathic medical care without improvement. She was evaluated in a foreign country one week prior to admission and was advised [...]
Abstract Number: 0608
SHM Converge 2025
Case Presentation: 26-year-old man diagnosed with T-cell acute lymphoblastic leukemia (T-ALL) with CNS involvement in July 2022 completed one cycle of hyperCVAD B and subsequently received maintenance therapy with POMP (prednisone, vincristine, methotrexate, and mercaptopurine) starting in 2023, along with intrathecal chemotherapy. The patient achieved complete remission, with serial MRIs, PET scans, and bone marrow [...]